EP0554436A1 — Gaba receptor modulators
Assigned to Euro Celtique SA · Expires 1993-08-11 · 33y expired
What this patent protects
The invention relates to a method, compositions and compounds for modulating the excitability of the brain, so as to obtain an improvement in stress, anxiety, insomnia and seizures using certain steroid derivatives acting on a newly identified site on the gamma-aminobutyric acid …
USPTO Abstract
The invention relates to a method, compositions and compounds for modulating the excitability of the brain, so as to obtain an improvement in stress, anxiety, insomnia and seizures using certain steroid derivatives acting on a newly identified site on the gamma-aminobutyric acid / chloride ionophore receptor complex (GR).
Drugs covered by this patent
- Zurzuvae (ZURANOLONE) · Biogen
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.